Skip to main content

Balchem Corporation Value Stock - Dividend - Research Selection

Balchem corporation

ISIN: US0576652004 , WKN: 905650

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield%
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



DescriptionData
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment also offers microencapsulation solutions; and human grade choline nutrients and mineral amino acid chelated products for wellness applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment offers ethylene oxide primarily for use in the health care industry; and single use canisters with ethylene oxide for sterilizing re-usable devices. This segment also sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. The company sells its products through sales force, independent distributors, and sales agents. Balchem Corporation was incorporated in 1967 and is headquartered in New Hampton, New York.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Balchem Corp Executive Roles Shift and Expand Responsibilities

2024-03-29
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Tuesday Talk: Still Talk Of The Town - Inflation

2024-03-19
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Time To Buy These Top-Rated Basic Materials Stocks Amid An Uptick In Inflationary Data

2024-03-19
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

The Zacks Analyst Blog Highlights Atmos Energy, Balchem, Cardinal Health, Casey's and Colgate-Palmolive

2024-03-18
Atmos Energy, Balchem, Cardinal Health, Casey's and Colgate-Palmolive are included in this Analyst Blog.

5 Low-Beta Stocks for Safe Returns as Inflation Rises Again

2024-03-15
Low-beta stocks like Atmos Energy Corporation (ATO), Balchem Corporation (BCPC), Cardinal Health, Inc. (CAH), Casey's General Stores, Inc. (CASY) and Colgate-Palmolive Company (CL) are a safe bet amid the ongoing market volatility.

Are Balchem Corporation (NASDAQ:BCPC) Investors Paying Above The Intrinsic Value?

2024-03-12
Key Insights The projected fair value for Balchem is US$125 based on 2 Stage Free Cash Flow to Equity Balchem's US$156...

Director Matthew Wineinger Sells Shares of Balchem Corp (BCPC)

2024-03-07
Director Matthew Wineinger has executed a sale of 1,333 shares of Balchem Corp (NASDAQ:BCPC) on March 4, 2024, according to a recent SEC filing.

Balchem Corporation to Participate at the BNP Paribas Exane 12th Consumer Ingredients Conference on March 14, 2024

2024-02-29
MONTVALE, N.J., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will participate at the BNP Paribas Exane 12th Consumer Ingredients Conference on March 14, 2024. Ted Harris, Chairman of the Board, Chief Executive Officer, and President, Martin Bengtsson, Chief Financial Officer, and Allison Baurichter, Senior Director Investor Relations will participate at the conference. More inform

Insider Sell: VP & Chief Accounting Officer William Backus Sells 16,180 Shares of Balchem ...

2024-02-28
William Backus, VP & Chief Accounting Officer of Balchem Corp, executed a sale of 16,180 shares in the company on February 26, 2024, according to a recent SEC Filing.

Insider Sell: Balchem Corp's SVP & Chief Technology Officer Michael Sestrick Sold 11,100 Shares

2024-02-24
On February 21, 2024, Michael Sestrick, SVP & Chief Technology Officer of Balchem Corp (NASDAQ:BCPC), executed a sale of 11,100 shares of the company.